Nanosonics Limited (NNCSF)
USD 3.0
(-6.54%)
USD 3.0
(-6.54%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 6.16 Million AUD | 100.0% |
| 2023 | 7.83 Million AUD | -14.41% |
| 2022 | 9.15 Million AUD | 804.94% |
| 2021 | 1.01 Million AUD | -26.35% |
| 2020 | 1.37 Million AUD | 1707.89% |
| 2019 | 76 Thousand AUD | -85.44% |
| 2018 | 522 Thousand AUD | -44.82% |
| 2017 | 946 Thousand AUD | -29.87% |
| 2016 | 1.34 Million AUD | 12163.64% |
| 2015 | 11 Thousand AUD | -99.86% |
| 2014 | 8.11 Million AUD | 7.27% |
| 2013 | 7.56 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.63 Million AUD | 0.0% |
| 2024 FY | 6.16 Million AUD | -21.38% |
| 2024 Q4 | 6.16 Million AUD | 0.0% |
| 2024 Q3 | - AUD | 0.0% |
| 2024 Q1 | 7.63 Million AUD | 100.0% |
| 2023 Q2 | 8.77 Million AUD | 0.0% |
| 2023 FY | 7.83 Million AUD | -14.41% |
| 2023 Q4 | 7.83 Million AUD | 0.0% |
| 2023 Q1 | 8.77 Million AUD | -4.21% |
| 2023 Q3 | 7.83 Million AUD | -10.65% |
| 2022 FY | 9.15 Million AUD | 804.94% |
| 2022 Q3 | 9.15 Million AUD | 151.94% |
| 2022 Q4 | 9.15 Million AUD | 0.0% |
| 2022 Q2 | 3.63 Million AUD | 0.0% |
| 2022 Q1 | 3.63 Million AUD | 259.19% |
| 2021 Q4 | 1.01 Million AUD | 0.0% |
| 2021 Q2 | 1.28 Million AUD | 0.0% |
| 2021 Q1 | 1.28 Million AUD | -6.7% |
| 2021 FY | 1.01 Million AUD | -26.35% |
| 2021 Q3 | 1.01 Million AUD | -21.06% |
| 2020 Q1 | 876 Thousand AUD | 1052.63% |
| 2020 Q3 | 1.37 Million AUD | 56.85% |
| 2020 Q4 | 1.37 Million AUD | 0.0% |
| 2020 FY | 1.37 Million AUD | 1707.89% |
| 2020 Q2 | 876 Thousand AUD | 0.0% |
| 2019 Q3 | 76 Thousand AUD | -74.83% |
| 2019 Q4 | 76 Thousand AUD | 0.0% |
| 2019 FY | 76 Thousand AUD | -85.44% |
| 2019 Q1 | 302 Thousand AUD | -42.15% |
| 2019 Q2 | 302 Thousand AUD | 0.0% |
| 2018 Q2 | 736 Thousand AUD | 0.0% |
| 2018 Q4 | 522 Thousand AUD | 0.0% |
| 2018 FY | 522 Thousand AUD | -44.82% |
| 2018 Q3 | 522 Thousand AUD | -29.08% |
| 2018 Q1 | 736 Thousand AUD | -22.2% |
| 2017 Q4 | 946 Thousand AUD | 0.0% |
| 2017 Q2 | 1.15 Million AUD | 0.0% |
| 2017 Q1 | 1.15 Million AUD | -14.75% |
| 2017 FY | 946 Thousand AUD | -29.87% |
| 2017 Q3 | 946 Thousand AUD | -17.74% |
| 2016 FY | 1.34 Million AUD | 12163.64% |
| 2016 Q3 | 1.34 Million AUD | -12.63% |
| 2016 Q2 | 1.54 Million AUD | 0.0% |
| 2016 Q4 | 1.34 Million AUD | 0.0% |
| 2016 Q1 | 1.54 Million AUD | 13936.36% |
| 2015 Q3 | 11 Thousand AUD | -99.87% |
| 2015 Q1 | 8.18 Million AUD | 0.85% |
| 2015 Q4 | 11 Thousand AUD | 0.0% |
| 2015 FY | 11 Thousand AUD | -99.86% |
| 2015 Q2 | 8.18 Million AUD | 0.0% |
| 2014 Q2 | 7.84 Million AUD | 0.0% |
| 2014 Q4 | 8.11 Million AUD | 0.0% |
| 2014 FY | 8.11 Million AUD | 7.27% |
| 2014 Q1 | 7.84 Million AUD | 3.64% |
| 2014 Q3 | 8.11 Million AUD | 3.51% |
| 2013 Q3 | 7.56 Million AUD | 7.34% |
| 2013 FY | 7.56 Million AUD | 0.0% |
| 2013 Q2 | 7.04 Million AUD | 0.0% |
| 2013 Q4 | 7.56 Million AUD | 0.0% |
| 2013 Q1 | 7.04 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 99.126% |
| Ansell Limited | 706.6 Million USD | 99.128% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 72.505% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -885.92% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.497% |
| ConvaTec Group Plc | 1.22 Billion USD | 99.498% |
| Encision Inc. | 67.33 Thousand USD | -9051.123% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -1509.562% |
| LifePoint, Inc. | 151.73 Thousand USD | -3961.054% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -25.397% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -901.951% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -3324.037% |
| SmileDirectClub, Inc. | 849.37 Million USD | 99.275% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 97.077% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -12608.037% |
| Vasamed, Inc. | 18.95 Thousand USD | -32417.15% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -33265.822% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -1478.199% |